SCHEMBL7828151

SCHEMBL7828151

COc1cccc(N2CCN(C(=O)C[O])CC2)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.63
MAPT P10636 3/20 0.60
KMT2A Q03164 3/20 0.59
MEN1 O00255 1/20 0.59
CYP1A2 P05177 1/20 0.59
CYP3A4 P08684 1/20 0.59
CYP2C9 P11712 1/20 0.59
CYP2C19 P33261 1/20 0.59
ADAMTS5 Q9UNA0 1/20 0.58
TP53 P04637 1/20 0.57
LDHA P00338 1/20 0.57
ALDH1A1 P00352 1/20 0.57
GAA P10253 1/20 0.56
DRD2 P14416 1/20 0.56
KCNH2 Q12809 1/20 0.56
TSHR P16473 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
MAPK1 P28482 1/20 0.55
CCR1 P32246 1/20 0.54
ADAMTS4 O75173 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14224740 0.89 LMNA (0.63) LMNAMAPTKMT2AMEN1CYP1A2
SCHEMBL9579424 0.87 MAPT (0.62) LMNAMAPTKMT2AMEN1CYP1A2
SCHEMBL27739890 0.85 KMT2A (0.65) LMNAMAPTKMT2AMEN1CYP1A2
Hydrochloric Acid SCHEMBL27918226 0.84 KMT2A (0.63) LMNAMAPTKMT2AMEN1CYP1A2
SCHEMBL4319359 0.84 KMT2A (0.63) LMNAMAPTKMT2AMEN1CYP1A2
SCHEMBL8321177 0.84 KMT2A (0.63) LMNAMAPTKMT2AMEN1CYP1A2
SCHEMBL4073099 0.83 SMN1; SMN2 (0.71) LMNAMAPTKMT2AMEN1CYP1A2
SCHEMBL7058493 0.82 KMT2A (0.62) LMNAMAPTKMT2AMEN1CYP1A2
SCHEMBL27382893 0.82 HTR1A (0.66) LMNAMAPTKMT2AMEN1CYP1A2
SCHEMBL28083199 0.82 KMT2A (0.62) LMNAMAPTKMT2AMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0454501-B1 Benzylidenethiazolidine derivatives, their preparation and their use for the inhibition of lipid peroxides SANKYO CO (JP) 2001-09-05 EP disclosed
EP-0839812-A1 Preparation of benzylthiazolidine derivatives Sankyo Company Limited (JP) 1998-05-06 EP disclosed
US-5387596-A Treating arteriosclerosis SANKYO COMPANY, LIMITED (JP) 1995-02-07 US disclosed
EP-0454501-A2 Benzylidenethiazolidine derivatives, their preparation and their use for the inhibition of lipid peroxides Sankyo Company Limited (JP) 1991-10-30 EP disclosed